{"nctId":"NCT03824938","briefTitle":"Aspirin for Exercise in Multiple Sclerosis (ASPIRE)","startDateStruct":{"date":"2019-04-30","type":"ACTUAL"},"conditions":["Multiple Sclerosis"],"count":60,"armGroups":[{"label":"Aspirin","type":"EXPERIMENTAL","interventionNames":["Drug: Aspirin 650mg Oral Capsule"]},{"label":"Acetaminophen","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Acetaminophen Tablet 650mg"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]}],"interventions":[{"name":"Aspirin 650mg Oral Capsule","otherNames":["Aspirin"]},{"name":"Acetaminophen Tablet 650mg","otherNames":["Acetaminophen"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosis of relapsing-remitting MS\n* self-reported heat-sensitivity to exercise\n* Expanded Disability Status Scale (EDSS) total score ≤ 6.0\n* exacerbation-free (and no use of corticosteroids) for 6 weeks prior\n* BMI ≤ 40\n\nExclusion Criteria:\n\n* prior history of significant head injury, stroke, or other neurological disease/disorder\n* current daily use of antipyretics or pain medication\n* currently in a major depressive episode\n* vascular disease of the legs, uncontrolled high blood pressure\n* uncontrolled diabetes mellitus or problem with blood sugar levels\n* contraindications to aspirin use (history of confirmed peptic ulcer, gastrointestinal or severe gynecological bleeding)\n* tarry stool or known fecal occult blood\n* uncontrolled syndrome of asthma, rhinitis, or nasal polyps\n* contraindications to acetaminophen use (severe active hepatic disease, Hepatitis C Virus)","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Time-to-exhaustion","description":"Duration of time exercising before reaching peak exertion, defined as cadence drop below 40 revolutions per minute (RPM) for \\>/= 5 seconds, or patient reaches volitional exhaustion in accordance with American Thoracic Society standard test termination criteria.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"551.7","spread":"78.4"},{"groupId":"OG001","value":"331.6","spread":"76.6"},{"groupId":"OG002","value":"578.2","spread":"82.1"}]}]}]},{"type":"PRIMARY","title":"Exercise-induced Body Temperature Change","description":"Change in body temperature from pre- to post- maximal exercise test.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.68","spread":"0.35"},{"groupId":"OG001","value":"0.006","spread":"0.32"},{"groupId":"OG002","value":"0.31","spread":"0.35"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":32},"commonTop":[]}}}